Ryskamp, Daniel A.
Frye, Amber M.
Phuong, Tam T. T.
Yarishkin, Oleg
Jo, Andrew O.
Xu, Yong
Lakk, Monika
Iuso, Anthony
Redmon, Sarah N.
Ambati, Balamurali
Hageman, Gregory
Prestwich, Glenn D.
Torrejon, Karen Y.
Križaj, David
Article History
Received: 22 April 2016
Accepted: 4 July 2016
First Online: 11 August 2016
Competing interests
: D.K. is a founder of, and D.A.R. and G.P. hold stock in, Asha Vision, which has licensed the TRPV4 inhibitor compounds from the U of Utah (US Patent App. 14/400,521, 2013). Other authors declare no completing interests.